Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan M Blum

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Translational Cancer Research|January 28, 2014
Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosisChang-Lung Lee, Jordan M Blum, David G Kirsch
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Methods to generate genetically engineered mouse models of soft tissue sarcomaRebecca D Dodd, Leonor Añó, Jordan M Blum, et al.
Cancer Research|December 16, 2014
Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathwayDavid Van Mater, Leonor Añó, Jordan M Blum, et al.
Nature Communications|September 25, 2015
Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphomaChang-Lung Lee, Katherine D Castle, Everett J Moding, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Translational Cancer Research|January 28, 2014
Role of p53 in regulating tissue response to radiation by mechanisms independent of apoptosisChang-Lung Lee, Jordan M Blum, David G Kirsch
Methods in Molecular Biology (Clifton, N.J.)|February 1, 2015
Methods to generate genetically engineered mouse models of soft tissue sarcomaRebecca D Dodd, Leonor Añó, Jordan M Blum, et al.
Cancer Research|December 16, 2014
Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathwayDavid Van Mater, Leonor Añó, Jordan M Blum, et al.
Nature Communications|September 25, 2015
Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphomaChang-Lung Lee, Katherine D Castle, Everett J Moding, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activityAlexander Muik, Homer C Adams 3rd, Friederike Gieseke, et al.
Journal for Immunotherapy of Cancer|April 11, 2025
Acasunlimab, an Fc-inert PD-L1×4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effectsMichela Capello, Angelica Sette, Theo Plantinga, et al.
Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.
Pageof 1